8 completed, 7 terminated, 4 unknown, 4 withdrawn. 27 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 27 | Completed 8, Terminated 7, Unknown 4, Withdrawn 4, Recruiting 2, Active not recruiting 1, Suspended 1 |
| Phase 1 | 2 | Withdrawn 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Carotid Stenosis: new trials by email Literature Review of Carotid Stenosis trials Research Report on Carotid Stenosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAROTID STABILISE Pilot: Alirocumab for Symptomatic Carotid Stenosis Alirocumab, Matching placebo - Carotid Artery Stenosis | Phase 2 | Completed | Middle East North Africa Stroke and Interventional Neurotherapies Organization | 40 | 2026-01-06 | 2026-11-16 |
| [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease [18F]AlF-OC - Stroke (CVA) or TIA, Carotid Artery Plaque | Phase 2 | Recruiting | Universitaire Ziekenhuizen KU Leuven | 24 | 2025-03-18 | 2025-08-11 |
| Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2 [18F]DPA-714 PET/MRI - CAROTID STENOSIS | Phase 2 | Recruiting | Hospices Civils de Lyon | 20 | 2024-02-13 | 2025-02-06 |
| Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis 68GaNOTA-Anti-MMR-VHH2 - Solid Malignancy Located in the Head and Neck, Cancer | Phase 2 | Terminated | Universitair Ziekenhuis Brussel | 29 | 2021-01-26 | 2026-06-01 |
| Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation 18F-FPPRGD2, Positron emission tomography, Computed tomography - Aortic Aneurysm, Abdominal, Carotid Atherosclerosis | Phase 2 | Withdrawn | Stanford University | 2019-10-01 | 2021-05-21 | |
| Imaging of Unstable Carotid Plaque in Patient Referred to Endarterectomy Sodium fluoride F-18 PET imaging - Carotid Artery Stenosis | Phase 2 | Unknown | University Hospital, Caen | 20 | 2018-09-03 | 2020-01-13 |
| Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting Terazosin, Carotid artery stenting - Carotid Artery Stenosis | Phase 2 | Unknown | Capital Medical University | 160 | 2018-03-02 | 2018-12-11 |
| New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques Contrast-enhanced ultrasound, Shear Wave Elastography, Ultrasound Examination - Carotid Artery Plaque | Phase 2 | Completed | Mayo Clinic | 54 | 2017-11-15 | 2022-11-25 |
| Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine Herbal Medicine C-117, The Placebo of Herbal Medicine C-117 - Carotid Artery Plaque | Phase 2 | Unknown | Guangzhou University of Traditional Chinese Medicine | 120 | 2017-03-01 | 2017-03-07 |
| The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition Imaging with flutemetamol F 18 PET/CT - Cognitive Impairment, Carotid Artery Plaque | Phase 2 | Active not recruiting | Scott Mcnally | 45 | 2017-02-17 | 2026-05-13 |
| Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Atorvastatin, Placebo - Nasopharyngeal Carcinoma, Radiation Therapy Complication | Phase 2 | Suspended | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 324 | 2017-01-01 | 2017-12-04 |
| Ticagrelor Versus Clopidogrel in Carotid Artery Stenting Ticagrelor, Clopidogrel, Aspirin - Carotid Artery Stenosis | Phase 2 | Completed | University Hospital, Basel, Switzerland | 210 | 2016-12-01 | 2022-06-28 |
| 99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis 99mTc-rhAnnexin V-128 - Carotid Artery Plaque | Phase 2 | Terminated | Advanced Accelerator Applications | 39 | 2016-06-23 | 2020-10-09 |
| The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Carotid Artery Stenosis EP 1645/Solution For Injection, 99mTC - Carotid Stenosis | Phase 2 | Unknown | Technische Universität Dresden | 21 | 2015-01-01 | 2012-02-03 |
| TRACER RGD-K5 Carotid Plaque Imaging Study [F-18] RDG-K5 - Carotid Artery Disease, Carotid Stenosis | Phase 2 | Terminated | The Cleveland Clinic | 3 | 2013-11-01 | 2017-09-12 |
| Revacept in Symptomatic Carotid Stenosis Revacept, Placebo - Carotid Stenosis, Atherosclerosis | Phase 2 | Completed | AdvanceCor GmbH | 158 | 2013-03-08 | 2021-01-28 |
| Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting Remote ischemic preconditioning, Sham remote ischemic preconditioning, Carotid Artery Stenting - Carotid Artery Stenosis | Phase 2 | Completed | Ji Xunming | 189 | 2012-07-01 | 2015-11-11 |
| [F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis [F-18]RDG-K5 - Carotid Stenosis | Phase 2 | Terminated | Siemens Molecular Imaging | 5 | 2012-05-01 | 2013-09-27 |
| Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy ARC1779 Injection, Placebo (normal saline) - Intracranial Embolism, Cerebral Thromboembolism | Phase 2 | Terminated | Archemix Corp. | 100 | 2009-02-01 | 2010-02-10 |
| Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis Fasudil Hydrochloride, Placebo Oral Tablet - Carotid Stenosis | Phase 2 | Terminated | Brigham and Women's Hospital | 2 | 2008-03-13 | 2017-03-29 |
Showing 20 of 27. Sign in to see all of them.
Cerebrovascular Disorders (4) · Inflammation (4) · Stroke (4) · Atherosclerosis (3) · Carotid Artery Diseases (3) · Cardiovascular Diseases (2) · Heart Diseases (2) · Intracranial Embolism (2) · Vascular Diseases (2) · Amaurosis Fugax (1) · Aortic Aneurysm, Abdominal (1) · Cognitive Dysfunction (1) · Constriction, Pathologic (1) · Fatty Liver (1)
Arterial Occlusive Diseases (27) · Brain Diseases (27) · Central Nervous System Diseases (27) · Nervous System Diseases (27) · Cardiovascular Diseases (25) · Vascular Diseases (25) · Carotid Artery Diseases (24) · Cerebrovascular Disorders (23) · Pathological Conditions, Signs and Symptoms (6) · Arteriosclerosis (4) · Pathologic Processes (4) · Embolism and Thrombosis (3) · Eye Diseases (2) · Intracranial Embolism and Thrombosis (2) · Neoplasms by Histologic Type (2)
Aspirin (3) · 18F-RGD-K5 (1) · ARC 1779 (1) · Abciximab (1) · Atorvastatin (1) · Clopidogrel (1) · Control Groups (1) · Dipyridamole (1) · Embolic Protection Devices (1) · FPP(RGD)2 (1) · Injections (1) · Lovastatin (1) · Magnetic Resonance Imaging (1) · Minocycline (1) · Positron-Emission Tomography (1)
Brigham and Women's Hospital (2) · AdvanceCor GmbH (1) · Advanced Accelerator Applications (1) · Archemix Corp. (1) · Capital Medical University (1) · Emory University (1) · Guangzhou University of Traditional Chinese Medicine (1) · Hospices Civils de Lyon (1) · Ji Xunming (1) · Kensey Nash Corporation (1) · Mayo Clinic (1) · Middle East North Africa Stroke and Interventional Neurotherapies Organization (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Scott Mcnally (1) · Siemens Molecular Imaging (1)
United States (10) · Belgium (3) · China (3) · Germany (3) · United Kingdom (3) · France (2) · Canada (1) · Egypt (1) · Italy (1) · Malaysia (1) · Netherlands (1) · Switzerland (1) · Turkey (Türkiye) (1)
Balaji Tamarappoo, MD, PhD (2) · Anju Nohria, MD (1) · Christoph Schindler Schindler, MD (1) · Curt Furberg (1) · Edward Aten, MD (1) · Gary S Roubin, MD (1) · Holger Poppert, Prof. Dr. (1) · Hugh Markus, MD (1) · Ian M Loftus, MD (1) · Jianwen Guo, MD (1) · Joseph S McNally, MD, PhD (1) · Leo H Bonati, MD (1) · Mark Espeland (1) · Matthew W Urban (1)
PMID 21700934, PMID 24373555, PMID 24699052, PMID 28174194, PMID 30957581, PMID 31391862, PMID 35695006, PMID 36645250, PMID 37565307
2008 (1), 2023 (1), R01HL038194 (1), R37HL041619 (1)